1. Home
  2. BNTX vs GFS Comparison

BNTX vs GFS Comparison

Compare BNTX & GFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$108.51

Market Cap

24.8B

Sector

Health Care

ML Signal

HOLD

Logo GlobalFoundries Inc.

GFS

GlobalFoundries Inc.

HOLD

Current Price

$41.28

Market Cap

22.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNTX
GFS
Founded
2008
2009
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
24.8B
22.2B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
BNTX
GFS
Price
$108.51
$41.28
Analyst Decision
Strong Buy
Buy
Analyst Count
11
11
Target Price
$140.31
$41.18
AVG Volume (30 Days)
1.1M
5.7M
Earning Date
03-10-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,698,814,972.00
$6,791,000,000.00
Revenue This Year
$2.03
$1.21
Revenue Next Year
N/A
$6.07
P/E Ratio
N/A
N/A
Revenue Growth
3.70
0.25
52 Week Low
$81.20
$29.77
52 Week High
$126.77
$47.69

Technical Indicators

Market Signals
Indicator
BNTX
GFS
Relative Strength Index (RSI) 70.02 66.76
Support Level $105.16 $38.68
Resistance Level $109.28 $42.73
Average True Range (ATR) 2.35 1.38
MACD 1.52 0.39
Stochastic Oscillator 83.23 82.55

Price Performance

Historical Comparison
BNTX
GFS

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

About GFS GlobalFoundries Inc.

GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates, which remains its controlling shareholder today. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and employs about 13,000 people.

Share on Social Networks: